PubMed Health⌕ Search

Biomedical subjects

Paul D Stolley

Publications and source records attributed to Paul D Stolley.

2 recordsLinked to original sources

Hospital-based violence intervention programs work.

BACKGROUND: Hospital-based violence prevention programs have emerged at trauma centers nationwide; however, none has been thoroughly evaluated for effectiveness. Our Violence Intervention Program (VIP) conducted a prospective randomized control study to evaluate the effectiveness of intervention for repeat victims of violence. METHOD: Patients admitted between 1999 and 2001 for treatment of injuries inflicted by a violent act were identified. Repeat victims of violence on parole/probation were invited to join the study. Participants were given a history-gathering questionnaire and randomized into two groups. Cases (intervention [n = 56]) received intensive psychosocial follow-up services, family or group therapy, and assisted with substance abuse treatment. Controls (nonintervention [n = 44]) received standard medical treatment and follow-through in accordance with standard parole or probation procedures. RESULTS: There was no significant difference in the number of arrests in the two groups. The control group was three times more likely to be arrested for a violent crime, two times more likely to be convicted of any crime, and four times more likely to be convicted of a violent crime. The projected time of incarceration is significantly longer for the control group. Repeat violent criminal activity was significantly more evident in the control group. CONCLUSION: Significant differences exist between the VIP intervention and nonintervention groups in terms of the quantity and severity of criminal activity.

Adult↗

Serum selenium and the risk of cervical cancer among women in the United States.

OBJECTIVE: To explore the relationship between serum selenium and cervical cancer. METHODS: We conducted a case-control study of cervical cancer in five areas around Birmingham, AL; Chicago, IL; Denver, CO; Miami, FL; and Philadelphia, PA. Community controls were selected by random-digit dialing and were matched to invasive cervical cancer cases by age, race/ethnicity, and telephone exchange. Serum selenium was determined by neutron activation analysis. Logistic regression analysis controlling for known risk factors of cervical cancer, including human papillomavirus (HPV) type-16 measured serologically, was performed on 227 invasive cases, 127 in-situ cases, and 526 controls. RESULTS: Values of serum selenium ranged from 67.5 to 185.0 ng/ml. Adjusted odds ratios for invasive cervical cancer by quintile were: 1.0 (highest selenium), 1.1, 1.0, 0.8, and 1.0 (lowest selenium), p for trend = 0.82. Similar patterns were observed for Stage I invasive, and Stages II-IV invasive cases, suggesting severity of disease did not influence the null results. Although no associations were seen among current or never smokers, a protective effect of selenium was suggested among former smokers. Effect modification was not evident for other variables examined. CONCLUSIONS: This study does not support a relationship between serum selenium and invasive cervical cancer at typical serum selenium levels in the US.

Adult↗